Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro
暂无分享,去创建一个
[1] G. Kaplan,et al. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. , 1996, Journal of Infectious Diseases.
[2] Clifton E. Barry,et al. Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis , 1996, Science.
[3] D. Remick,et al. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates , 1996, Journal of leukocyte biology.
[4] G. Kaplan,et al. H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes , 1996, Infection and immunity.
[5] T. Wilson,et al. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis , 1995, Molecular microbiology.
[6] G. Kaplan,et al. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.
[7] P. D. Hart,et al. Stimulation or inhibition of the respiratory burst in cultured macrophages in a mycobacterium model: initial stimulation is followed by inhibition after phagocytosis , 1994, Infection and immunity.
[8] K. Smith,et al. Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes , 1993, Journal of Experimental Medicine.
[9] A. Izzo,et al. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity , 1993, The Journal of experimental medicine.
[10] V. Ramesh,et al. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients. , 1993, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[11] H. Binz,et al. Activation of human monocyte chemiluminescence response by acylpoly(1,3)galactosides derived from Klebsiella pneumoniae , 1992, Journal of leukocyte biology.
[12] M. Denis. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol , 1991, Clinical and experimental immunology.
[13] H. Tomioka,et al. Susceptibilities of Mycobacterium leprae and M. avium complex to the H2O2-Fe-mediated halogenation system supplemented with antimicrobial agents. , 1989, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[14] P. Mahadevan,et al. Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. , 1989, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[15] K. Stýblo,et al. Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. , 1989, Reviews of infectious diseases.
[16] S. Linas,et al. N,N'-dimethylthiourea dioxide formation from N,N'-dimethylthiourea reflects hydrogen peroxide concentrations in simple biological systems. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Verhoef,et al. Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems , 1987, Infection and immunity.
[18] S. Kaufmann,et al. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. , 1987, Journal of immunology.
[19] A. J. Crowle,et al. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages , 1986, Journal of clinical microbiology.
[20] M. Gottlieb,et al. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. , 1986, Reviews of infectious diseases.
[21] D. Armstrong,et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[22] S. Scully,et al. Relationship of superoxide production to cytoplasmic free calcium in human monocytes. , 1986, The Journal of clinical investigation.
[23] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[24] R. Steinman,et al. Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates , 1985, The Journal of experimental medicine.
[25] S. Klebanoff,et al. Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae , 1984, Infection and immunity.
[26] H. Murray,et al. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. , 1983, The Journal of clinical investigation.
[27] C. Nathan,et al. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.
[28] D. Morel,et al. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.
[29] H. Murray. Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates , 1981, The Journal of experimental medicine.
[30] H. Murray,et al. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation , 1980, The Journal of experimental medicine.
[31] M. Sasada,et al. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of candida by macrophages , 1980, The Journal of experimental medicine.
[32] C. Nathan,et al. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates , 1979, The Journal of experimental medicine.
[33] V. Aber,et al. Virulence of Mycobacterium tuberculosis and susceptibility to peroxidative killing systems. , 1978, Journal of general microbiology.
[34] N. Pellis,et al. Effects of Normal and Activated Cell Fractions on the Growth of Tubercle Bacilli , 1972, Infection and immunity.
[35] S. Sulavik,et al. Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defensive Mechanisms , 1966, The Yale Journal of Biology and Medicine.
[36] N. Rose,et al. OXYGEN INHIBITION OF GROWTH OF MYCOBACTERIUM TUBERCULOSIS , 1964, Journal of bacteriology.
[37] D. Mitchison,et al. VIRULENCE IN THE GUINEA-PIG, SUSCEPTIBILITY TO HYDROGEN PEROXIDE, AND CATALASE ACTIVITY OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN AND BRITISH PATIENTS. , 1963, The Journal of pathology and bacteriology.
[38] L. Horwitz,et al. Hydrogen peroxide cytotoxicity in cultured cardiac myocytes is iron dependent. , 1994, The American journal of physiology.
[39] S. Kaufmann,et al. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. , 1994, International immunology.
[40] M. Denis. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. , 1991, Cellular immunology.
[41] R. Locksley,et al. Oxygen‐dependent microbicidal systems of phagocytes and host defense against intracellular protozoa , 1983, Journal of cellular biochemistry.
[42] V. Aber,et al. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. , 1978, Journal of general microbiology.